A review of the participation of DDIT4 in the tumor immune microenvironment through inhibiting PI3K-Akt/mTOR pathway
DDIT4 (DNA Damage Inducible Transcript 4), a well-established inhibitor of the PI3K-Akt/mTOR pathway, is upregulated under cellular stress conditions. Extensive research has demonstrated that DDIT4 expression is aberrantly elevated in various malignancies, where it exhibits context-dependent roles i...
Saved in:
| Main Authors: | Yunshu Jiao, Yang Xiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1595463/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DDIT4/mTOR signaling pathway mediates cantharidin-induced hepatotoxicity and cellular damage
by: Wenchao Tang, et al.
Published: (2024-11-01) -
ОСТЕОСАРКОМА ПОЗВОНОЧНИКА — СОВРЕМЕННАЯ КЛАССИФИКАЦИЯ, РОЛЬ СИГНАЛЬНОГО ПУТИ mTOR, ПЕРСПЕКТИВЫ ТЕРАПИИ (ОБЗОР ЛИТЕРАТУРЫ)
by: Илья Андреевич Баранов, et al.
Published: (2025-06-01) -
The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma
by: Ilaria Versari, et al.
Published: (2025-02-01) -
Synergistic Antitumor Effects of Ivermectin and Metformin in Canine Breast Cancer via PI3K/AKT/mTOR Pathway Inhibition
by: Huili Feng, et al.
Published: (2025-05-01) -
Research on the role and mechanism of the PI3K/Akt/mTOR signalling pathway in osteoporosis
by: Chuanlong Liu, et al.
Published: (2025-05-01)